Cornell Pochily Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
Cornell Pochily Investment Advisors, Inc.
- $262 Million
- Q2 2024
A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 14,013 shares of BMY stock, worth $759,224. This represents 0.22% of its overall portfolio holdings.
Number of Shares
14,013
Previous 11,055
26.76%
Holding current value
$759,224
Previous $599,000
3.01%
% of portfolio
0.22%
Previous 0.24%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,404Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.6 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.95 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.04 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.2 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...